Truscreen Group Ltd (tru) Logo

Truscreen Group Ltd (TRU)

___:___ · AUD

TRU Chart

TRU's Principal Activity is the the development, manufacture and sale of cancer detection devices and systems.

Share Price Activity

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume (4w avg)
Day Range -
Prev Close
Last Trade


1 Week
1 Month
2021 YTD
1 Year
vs Sector (1yr) -
vs ASX 200 (1yr) -57.79%


Market Capitalisation
ASX Rank 1,670 of 2,295
Sector Rank

Key Information

Shares Issued
Sector Healthcare
Similar Companies -
EPS $0.00
DPS $0.00
NTA per share $0.00

Broker Consensus

TRU is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.


Date Heading Pages File Size Time

Company Overview

Truscreen Group Limited (TRU) is the manufacturer and owner of the TruScreen Cervical Cancer Screening System. TruScreen's real time cervical cancer technology utilises a digital wand which is placed on the surface of the cervix to measure electrical and optical signals from the surrounding tissue.

Incorporation Details

No incorporation details available.

Corporate Details

Head Office Sydney NSW 2000
Registry Link Market Services
Auditor -
Date Listed 6 Jan 2021

Upcoming Calendar (Forecasted)

Date Event
30/05/2022 Report (Prelim)
29/06/2022 Report (Annual)

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
15/10/2013 $0.17 100% $0.2429 Interim 05/11/2013
29/04/2013 $0.18 100% $0.2571 Final 17/05/2013
17/10/2012 $0.12 100% $0.1714 Interim 08/11/2012
02/05/2012 $0.18 100% $0.2571 Final 24/05/2012
22/11/2011 $0.17 100% $0.2429 Interim 14/12/2011
27/04/2011 $0.18 100% $0.2571 Final 16/05/2011
21/10/2010 $0.17 100% $0.2429 Interim 11/11/2010
05/05/2010 $0.165 100% $0.2357 Final 25/05/2010
22/10/2009 $0.172 100% $0.2457 Interim 12/11/2009
30/04/2009 $0.22 100% $0.3143 Final 20/05/2009

See Upcoming Dividends for all ASX companies.

Key Data
DPS(TTM) $0.00
Gross DPS(TTM) $0.00
Dividend yield
Gross yield
Payout Ratio --
DRP Features -

Directors & Management

Directors & Management

Name Title Since Bio
Dr Dexter Cheung Non-Executive Director Mar 2021 Director Bio icon

Dr Dexter Cheung

Non-Executive Director

Dr Cheung has a technical background in opto-electronics and has more than 20 years' experience in medical device engineering. He is the Research & Development Manager of the respiratory humidification division of Fisher & Paykel Healthcare, an NZX/ASX listed healthcare company involved in respiratory medical devices. Dr Cheung has knowledge of manufacturing processes and has travelled to China, the USA, Europe, United Kingdom and Japan, working closely with medical device manufacturers and component suppliers in these regions. Dr Cheung has published eight papers and has eight international patents pending or granted jointly with collaborators or in his name, focusing on respiratory air-flow management. He has previously served on a visiting committee of the Auckland University of Technology.

Ms Juliet Hull Chief Executive Officer,Executive Director Sep 2020 Director Bio icon

Ms Juliet Hull

Chief Executive Officer,Executive Director

Ms Hull's leadership experience included working within the healthcare sectors in Australia and New Zealand with distributors and public health systems across Greater Asia and Pacific. She was previously the General Manager and Country Director of Johnson & Johnson New Zealand.

Mr Guy Adrian Robertson Chief Financial Officer,Company Secretary Nov 2018
Mr Anthony (Tony) Peng Ho Non-Executive Chairman,Non-Executive Director Oct 2018 Director Bio icon

Mr Anthony (Tony) Peng Ho

Non-Executive Chairman,Non-Executive Director

Mr Ho is an experienced company director having held executive directorships and chief financial officer roles with a number of ASX listed companies. Tony was executive director of Arthur Yates & Co Limited, retiring from that position in April 2002. His corporate, general management and governance experience includes being chief financial officer/finance director of M.S. McLeod Holdings Limited, Galore Group Limited, the Edward H O'Brien group of companies. Mr Ho is currently the chairman of ASX listed Greenland Minerals Limited (ASX:GGG), Bioxyne Limited (ASX: BXN), Credit intelligence Limited (ASX:CI1), and Cannasouth Limited (NZX: CBD). He was previously chairman of Esperance Minerals Limited and a non-executive director Hastings Technology Metals Limited. Tony was the past non-executive chairman of St. George Community Housing Limited (November 2002 to December 2009). Prior to joining commerce, Mr Ho was a partner of Cox Johnston & Co, Chartered Accountants, which has since merged with Ernst & Young.He was a past Fellow of the Australian Marketing Institute.

Mr Christopher Horn Non-Executive Director Nov 2013 Director Bio icon

Mr Christopher Horn

Non-Executive Director

Mr Horn is an experienced business executive and has acted in a number of management roles including 20 years as a partner of KPMG and its predecessor firms. He is a director of a number of private companies across a broad range of business activities including corporate advisory, financial services, and funds management. He is also Chair of Finance and Risk Committee of the Truscreen.

Director Transactions

TRU directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
20/07/21 Christopher (Chris) Lawrence Sell +4,467,169 $0.068 ($302,302) On-market trade
02/07/21 Christopher (Chris) Lawrence Sell +1,465,695 $0.069 ($101,761) On-market trade
02/06/21 Christopher (Chris) Lawrence Sell +418,818 $0.078 ($32,736) On-market trade
06/01/21 Anthony (Tony) Ho Buy +100,000 $0.09 $9,000 On-market trade

Director Interests

The current holdings of TRU directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Dexter Cheung 01/03/2021 0 N/A N/A N/A
Anthony (Tony) Ho 06/01/2021 N/A 3,600,000 N/A N/A
Juliet Hull N/A N/A N/A N/A N/A
Christopher Horn N/A N/A N/A N/A N/A

Shareholder Info

Top 20 Shareholders About the Data

Data supplied by Morningstar and accurate on Dec 30, 2020.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
New Zealand Depository Nominee 30,362,441 8.41%
Consolidated Nominees Pty Ltd (i) 29,539,900 8.18%
New Zealand Central Securities Depository Limited 23,049,754 6.39%
Browns Island Holdings Limited 22,400,000 6.21%
Waitara Trustees Limited 18,622,222 5.16%
Masfen Securities Limited 13,499,645 3.74%
Albert Nominees Limited 11,000,000 3.05%
Consolidated Nominees Pty Ltd (ii) 10,062,500 2.79%
Forsyth Barr Custodians Limited 10,003,610 2.77%
Idl Trustee Limited 9,850,000 2.73%
Maarten Arnold Janssen 4,964,170 1.38%
Ryan Peter Parkin 4,665,428 1.29%
David Russell Stewart & Adrienne Ruth Stewart 4,138,995 1.15%
Melda Super Pty Limited 3,500,000 0.97%
Caroline Robyn Ball & Christopher John Thomson Bush 2,978,681 0.83%
Anthony Peng Ho & Chui Hoong Ho 2,400,000 0.66%
Custodial Services Limited 2,367,499 0.66%
Mark David John Williams 2,321,429 0.64%
Qsp Limited 2,312,790 0.64%
Timothy James Macintosh 2,276,619 0.63%

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 24 199 266 849 336 1,674

Substantial Shareholders

No Substantial Shareholders for TRU in our database.

Shareholders Buying

12 month transaction history compiled from ASX announcements.

No buy transactions reported by Substantial Shareholders in the past 12 months.

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
No Financial Year End data available
Page Icon
TRU Historical Price Data (CSV)
Up to 20 years of EOD share price history
Lock Icon
You must be logged in to access this feature. Please sign up for free or login.
Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.